Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Natriuretic Peptides
100%
Novel Therapeutics
57%
Cyclic GMP
42%
Guanylate Cyclase
28%
Cardiorenal Syndrome
21%
NPR-A
21%
Large Animal Model
21%
Particulate Guanylyl Cyclase
21%
Cardiovascular Disease
21%
Guanylyl Cyclase Receptor
14%
Hypertensive Heart Disease
14%
Therapeutic Potential
14%
Peptide Drugs
14%
Gene Therapy
14%
Cell Therapy
14%
Integrative Physiology
14%
Natriuretic Peptide System
14%
Physiologic
14%
Innovative Therapies
14%
Cardiomyocyte Function
14%
Diastolic Heart Failure
14%
New-onset Heart Failure
7%
Gene Variants
7%
Pleiotropic Effects
7%
Vasodilatation
7%
Physician-scientist
7%
Collaborative Teams
7%
Hypertension
7%
Oral Delivery
7%
Designer Natriuretic Peptide
7%
Redfield
7%
Vascular Regeneration
7%
Computational Drug Discovery
7%
Synergistic Action
7%
Murine Animal Model
7%
Impaired Renal Function
7%
Receptor Activation
7%
Overexpression
7%
Collagen Synthesis
7%
Renal Disease
7%
Aldosterone
7%
Natriuresis
7%
Novel Genes
7%
Lusitropism
7%
Beneficial Properties
7%
Cardiac Hypertrophy
7%
Gene Delivery
7%
Cyclic Guanosine Monophosphate Signaling
7%
Fibroblast Proliferation
7%
Cellular Level
7%
Pharmacologic
7%
Heart Failure
7%
Delivery Strategies
7%
Myocyte Apoptosis
7%
Biological Properties
7%
Novel Animal Model
7%
Receptor Regulation
7%
Treatment of Human Diseases
7%
Vasculature
7%
Cell Biology
7%
Human Physiology
7%
Center-based
7%
Cardiac Fibrosis
7%
Nitric Oxide
7%
Further Development
7%
Genetic Modification
7%
Receptor Function
7%
Kidney
7%
NPR-B
7%
Paracrine Factors
7%
Cardiovascular Structure
7%
Peptide Delivery
7%
Laboratory Research
7%
Clinical Research Center
7%
Molecular Biology
7%
Protective Behavior
7%
Autocrine Factor
7%
Cardiovascular Function
7%
Integrative Genes
7%
Cardiomyocyte Structure
7%
General Clinical
7%
Cardiac Fibroblast Activation
7%
Clinically Significant
7%
Circulating Factors
7%
Large Mammals
7%
Diastolic Function
7%
Cardiovascular Therapy
7%
Autocrine/paracrine
7%
Pharmacology, Toxicology and Pharmaceutical Science
Peptide
100%
Natriuretic Factor
100%
Guanylate Cyclase
47%
Cyclic GMP
40%
Receptor
38%
Cardiovascular Disease
21%
Diseases
17%
Brain Natriuretic Peptide
15%
Congestive Heart Failure
12%
Diastolic Heart Failure
11%
Heart Disease
10%
Gene Delivery
6%
Drug Discovery
6%
Paratuberculosis
6%
Hypertension
6%
Kidney Disease
6%
Guanylate Cyclase Activator
6%
Aldosterone
6%
Mouse Model
5%
Clinical Research
5%
Nitric Oxide
5%
Heart Muscle Fibrosis
5%